FDA Import Refusal 8JB-0093850-4/11/50 — The Harvard Drug Group LLC

The Harvard Drug Group LLC — FEI 1818658

The FDA refused shipment 8JB-0093850-4/11/50 from The Harvard Drug Group LLC (United States) on March 22, 2023. The refused product falls under Drugs and Biologics — OXYMETAZOLINE HCL (ADRENERGIC). Cited charge: 179 This firm has 5 or more other import refusals on record.